Suppr超能文献

在埃塞俄比亚,接受多药耐药结核病治疗的患者的生存状况及其预测因素:多中心观察性研究。

Survival status and its predictors among multi-drug resistance tuberculosis treated patients in Ethiopia: Multicenter observational study.

机构信息

School of Pharmacy, Institute of Health Science, Arba Minch University, Southern Nations, Nationalities and Peoples Region, Arba Minch, Ethiopia.

School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.

出版信息

PLoS One. 2020 Nov 9;15(11):e0241684. doi: 10.1371/journal.pone.0241684. eCollection 2020.

Abstract

BACKGROUND

Although substantial progress has been made in combating the crisis of multi-drug resistance tuberculosis (MDR-TB), it remained the major public health threat globally.

OBJECTIVE

To assess patients' survival and its predictors among patients receiving multi-drug resistance tuberculosis treatment at MDR-TB treatment centers of southern and southwestern Ethiopia.

METHODS

A multicenter retrospective observational study was conducted from April 14 to May 14, 2019, among patients receiving MDR-TB treatment at three MDR-TB treatment centers, Butajira, Arbaminch and Shenengibe Hospitals, located in south and southwestern Ethiopia. A total of 200 records were reviewed using a check list adopted from the national MDR-TB treatment charts and other relevant documents. Data were entered into Epi-Data version 4.2.0 for cleaning and exported to STATA-13 for analysis. Descriptive analysis was carried out and results were presented by text, tables, and charts. Kaplan-Meier (log-rank test) and Cox regression were used to compare baseline survival experience and to determine predictors of patients' survival (death), respectively. The adjusted hazard ratio (AHR) was used to measure the strength of association and a p-value of <0.05 was considered to declare statistical significance.

RESULTS

Of 200 patients, 108 (54%) of them were males. The mean (+ standard deviation) age of the study population was 32.9±9.5years. During follow-up, 22 (11%) deaths were reported. The overall incidence density of death was 11.99, 95% CI [7.89-18.21] per 100,000person-years. The median (interquartile range (IQR)) survival time was 375(249-457) days. Comorbidity (AHR = 23.68, 95% CI [4.85-115.46]), alcohol consumption (AHR = 4.53, 95% CI [1.21-16.97]), and history of poor adherence (AHR = 12.27, 95% CI [2.83-53.21]) were independently associated with patients' survival (death).

CONCLUSION

In this study, the incidence density of mortality was very high. Alcohol consumption, poor adherence, and the presence of comorbidity were independently associated with death. Hence, alcohol users, patients with comorbidity and poor adherence should be given due attention during therapy.

摘要

背景

尽管在应对耐多药结核病(MDR-TB)危机方面取得了重大进展,但它仍是全球主要的公共卫生威胁。

目的

评估在埃塞俄比亚南部和西南部的 MDR-TB 治疗中心接受耐多药结核病治疗的患者的生存情况及其预测因素。

方法

这是一项于 2019 年 4 月 14 日至 5 月 14 日在埃塞俄比亚南部和西南部的三家 MDR-TB 治疗中心(Butajira、Arbaminch 和 Shenengibe 医院)进行的多中心回顾性观察性研究。共对 200 份记录进行了审查,这些记录使用了从国家 MDR-TB 治疗图表和其他相关文件中采用的检查表。数据被输入到 Epi-Data 版本 4.2.0 进行清理,并导出到 STATA-13 进行分析。采用描述性分析,结果以文本、表格和图表呈现。Kaplan-Meier(对数秩检验)和 Cox 回归用于比较基线生存经验,并确定患者生存(死亡)的预测因素。调整后的危害比(AHR)用于衡量关联强度,p 值<0.05 被认为具有统计学意义。

结果

在 200 名患者中,有 108 名(54%)为男性。研究人群的平均(+标准差)年龄为 32.9±9.5 岁。在随访期间,报告了 22 例(11%)死亡。总的死亡发生率密度为 11.99,95%置信区间[7.89-18.21]为每 100,000 人年。中位(四分位间距(IQR))生存时间为 375(249-457)天。合并症(AHR = 23.68,95%置信区间[4.85-115.46])、饮酒(AHR = 4.53,95%置信区间[1.21-16.97])和既往服药依从性差(AHR = 12.27,95%置信区间[2.83-53.21])与患者的生存(死亡)有关。

结论

在这项研究中,死亡率的发生率密度非常高。饮酒、服药依从性差和合并症与死亡有关。因此,在治疗过程中,应关注饮酒者、合并症患者和服药依从性差的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8ad/7652297/c3d2c2a35aa0/pone.0241684.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验